Monoclonal immunoglobulins and autoantibodies in lymphoid malignancies

dc.contributor.authorKatsikis, P. D.en
dc.contributor.authorPavlidis, N. A.en
dc.contributor.authorPapadopoulos, N. M.en
dc.contributor.authorBai, M.en
dc.contributor.authorMoutsopoulos, H. M.en
dc.date.accessioned2015-11-24T19:03:55Z
dc.date.available2015-11-24T19:03:55Z
dc.identifier.issn0250-7005-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19945
dc.rightsDefault Licence-
dc.subjectAgeden
dc.subjectAntibodies, Monoclonal/*analysisen
dc.subjectAutoantibodies/*analysisen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectImmunoglobulin G/analysisen
dc.subjectImmunoglobulin M/analysisen
dc.subjectImmunoglobulins/*analysisen
dc.subjectLeukemia, Lymphocytic, Chronic, B-Cell/*immunologyen
dc.subjectLymphoma/*immunologyen
dc.subjectLymphoma, Non-Hodgkin/*immunologyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectReference Valuesen
dc.subjectRheumatoid Factor/analysisen
dc.titleMonoclonal immunoglobulins and autoantibodies in lymphoid malignanciesen
heal.abstractThe presence of serum monoclonal or oligoclonal immunoglobulins (paraproteins) was investigated in 38 non-Hodgkin's lymphoma and chronic lymphocytic leukemia patients, 33 patients with solid tumors and 33 healthy individuals. Seventy two percent of non-Hodgkin's lymphoma and 31% of chronic lymphocytic leukemia patients had serum paraproteins, in contrast to 21% and 15% of solid tumor patients and normal controls respectively. There was no significant prevalence of a certain isotype or light chain in the non-Hodgkin's lymphoma, chronic lymphocytic leukemia and solid tumor groups. In the healthy individuals all bands were monoclonal of the IgG isotype. No correlation was found between histologic grading of lymphoid malignancy or disease stage and serum monoclonality. No serologic or histologic autoimmune features were demonstrated in non-Hodgkin's lymphoma and chronic lymphocytic leukemia patients. In addition, no correlation was found between serum autoantibody activity and mono- or oligoclonal immunoglobulins.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/2285248-
heal.journalNameAnticancer Resen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate1990-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: